2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid
C13H17F3N4O5 — CID 171400083
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid
2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid (PubChem CID 171400083) has the molecular formula C13H17F3N4O5 and a molecular weight of 366.30 g/mol. Its IUPAC name is 2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid.
Molecular Properties
| Compound Name | 2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid |
|---|---|
| PubChem CID | 171400083 |
| Molecular Formula | C13H17F3N4O5 |
| Molecular Weight | 366.30 g/mol |
| Exact Mass | 366.12 |
| IUPAC Name | 2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-[[6-(trifluoromethyl)pyrazin-2-yl]amino]oxan-2-yl]methylamino]acetic acid |
| SMILES | O=C(O)CNC[C@H]1OC[C@H](Nc2cncc(C(F)(F)F)n2)[C@@H](O)[C@H]1O |
| InChI | InChI=1S/C13H17F3N4O5/c14-13(15,16)8-2-18-3-9(20-8)19-6-5-25-7(12(24)11(6)23)1-17-4-10(21)22/h2-3,6-7,11-12,17,23-24H,1,4-5H2,(H,19,20)(H,21,22)/t6-,7+,11+,12-/m0/s1 |
| InChIKey | DLHANDYNKKNIGR-QEPVFIOASA-N |
| XLogP | -0.93 |
| TPSA | 136.83 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 366.30 |
| LogP ≤ 5 | -0.93 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171400083 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.